Va Tech Wabag FY26 results: Net profit up 25% to ₹3,705 crore
Va Tech Wabag Ltd delivered record FY26 results with revenue up 19.7% to ₹39,442 crore and net profit rising 25.5% to ₹3,705 crore. The company declared a ₹5 per share dividend and maintains a ₹9,500 crore net cash position. Order book stands at ₹172 billion, driven by wins in India and the Middle East.

*this image is generated using AI for illustrative purposes only.
Va Tech Wabag reported record financial results for the fiscal year ended March 31, 2026, driven by strong execution in its core water treatment business and expansion into emerging sectors. The company’s revenue rose 19.7% year-on-year to ₹39,442 crore, while net profit after tax (PAT) climbed 25.5% to ₹3,705 crore. EBITDA expanded 21.8% to ₹5,241 crore, reflecting improved operating margins and efficient project delivery.
The board declared a final dividend of ₹5 per equity share for FY26, an increase from ₹4 per share in the previous year. Shareholders on record as of August 5, 2026, are eligible for the payout. The company also appointed Mr. Samaresh Parida as an independent director and approved the remuneration for related party Mr. Rohan Mittal during its 31st Annual General Meeting held on August 12, 2026.
Financial Performance
Va Tech Wabag’s financial metrics for FY26 demonstrate consistent growth across key parameters compared to FY25.
| Metric: | FY26 (₹ crore) | FY25 (₹ crore) | Growth |
|---|---|---|---|
| Revenue: | 39,442 | 32,940 | +19.7% |
| EBITDA: | 5,241 | 4,302 | +21.8% |
| Net Profit: | 3,705 | 2,953 | +25.5% |
The company achieved an EBITDA margin of 13.3% and a PAT margin of 9.4% for the fiscal year. Return on equity (RoE) stood at 15.7%, while return on capital employed (RoCE) was 19.4%, underscoring the efficiency of its asset-light business model.
What the Numbers Show
Va Tech Wabag’s ability to grow net profit faster than revenue indicates operational leverage. While revenue increased by 19.7%, EBITDA grew by 21.8% and net profit by 25.5%. This divergence suggests that cost management and margin accretion from high-value projects contributed significantly to bottom-line growth, rather than just top-line volume expansion.
Order Book and Cash Position
The company closed FY26 with a robust order book of over ₹172 billion, providing strong multi-year revenue visibility. This includes significant wins in desalination and municipal water projects across India and the Middle East. Notable orders include a 300 MLD desalination plant in Yanbu, Saudi Arabia, and a 45 MLD tertiary treated recycled water plant in Chennai.
Va Tech Wabag maintained a net cash-positive position of ₹9,500 crore (excluding HAM project borrowings) as of Q4 FY26. This marks the sixth consecutive year of net cash positivity, supported by disciplined working capital management and cash accruals from operations. The company’s credit rating was reaffirmed at IND AA- with a Stable Outlook.
Strategic Outlook
Management highlighted emerging opportunities in ultra-pure water for semiconductors, solar photovoltaic manufacturing, data centers, and green hydrogen. The company is actively pursuing projects in these sectors, leveraging its expertise in advanced water treatment and resource recovery. Additionally, Va Tech Wabag is expanding its presence in Compressed Bio-Gas (CBG) through strategic partnerships, aiming to convert biogas from wastewater treatment into renewable energy.
Historical Stock Returns for VA Tech Wabag
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.38% | -2.45% | -13.70% | +44.95% | +24.59% | +456.61% |
How will Va Tech Wabag's expansion into ultra-pure water for semiconductors and data centers impact its long-term revenue mix and margin profile compared to traditional municipal projects?
Given the robust ₹172 billion order book, what is the expected conversion rate of these orders into revenue over the next three fiscal years, and are there any geopolitical risks associated with the Middle East contracts?
How might the strategic push into Compressed Bio-Gas (CBG) partnerships affect the company's capital expenditure requirements and return on capital employed (RoCE) in the medium term?


































